Furthermore, Co‐Immunoprecipitation (Co‐IP) assays using AKT antibodies confirmed a direct interaction between YBX‐1 and AKT in RCC cells (Figure S4A, Supporting Information). The gene discussed is YBX1; the disease is renal cell adenocarcinoma.